These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26041134)

  • 1. Colistin: efficacy and safety in different populations.
    Shahbazi F; Dashti-Khavidaki S
    Expert Rev Clin Pharmacol; 2015; 8(4):423-48. PubMed ID: 26041134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin in critically ill patients.
    Boisson M; Gregoire N; Couet W; Mimoz O
    Minerva Anestesiol; 2013 Feb; 79(2):200-8. PubMed ID: 23241733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin: understanding and applying recent pharmacokinetic advances.
    Ortwine JK; Kaye KS; Li J; Pogue JM
    Pharmacotherapy; 2015 Jan; 35(1):11-6. PubMed ID: 25187500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin: Revival of an Old Polymyxin Antibiotic.
    Dijkmans AC; Wilms EB; Kamerling IM; Birkhoff W; Ortiz-Zacarías NV; van Nieuwkoop C; Verbrugh HA; Touw DJ
    Ther Drug Monit; 2015 Aug; 37(4):419-27. PubMed ID: 25549206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic evaluation of colistin sodium.
    Michalopoulos AS; Karatza DC; Gregorakos L
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.
    Lim LM; Ly N; Anderson D; Yang JC; Macander L; Jarkowski A; Forrest A; Bulitta JB; Tsuji BT
    Pharmacotherapy; 2010 Dec; 30(12):1279-91. PubMed ID: 21114395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetic and pharmacodynamic profiling of colistin in critically ill patients with multi-drug-resistant gram-negative bacterial infections, along with differences in clinical, microbiological and safety outcome.
    Ram K; Sheikh S; Bhati RK; Tripathi CD; Suri JC; Meshram GG
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):128-140. PubMed ID: 33245629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Shedding light on the use of colistin: still gaps to be filled].
    Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants: A Review of the Literature.
    Nakwan N; Chokephaibulkit K; Imberti R
    Pediatr Infect Dis J; 2019 Nov; 38(11):1107-1112. PubMed ID: 31469781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin: re-emergence of the 'forgotten' antimicrobial agent.
    Dhariwal AK; Tullu MS
    J Postgrad Med; 2013; 59(3):208-15. PubMed ID: 24029199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin pharmacokinetics: the fog is lifting.
    Couet W; Grégoire N; Marchand S; Mimoz O
    Clin Microbiol Infect; 2012 Jan; 18(1):30-9. PubMed ID: 21988234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bactericidal effect of colistin on Escherichia coli. Model and simulation or the pharmacokinetic-pharmacodynamic relation for prediction of efficacy in veterinary antibiotic therapy].
    Renard L; Gicquel M; Laurentie M; Sanders P
    Vet Res; 1996; 27(1):23-32. PubMed ID: 8620185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
    Zavascki AP; Nation RL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing colistin dosing: Is a loading dose necessary?
    Nazer LH; Anabtawi N
    Am J Health Syst Pharm; 2017 Jan; 74(1):e9-e16. PubMed ID: 28007716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
    Sorli L; Luque S; Li J; Rodríguez E; Campillo N; Fernandez X; Soldado J; Domingo I; Montero M; Grau S; Horcajada JP
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing.
    Mohamed AF; Cars O; Friberg LE
    J Antimicrob Chemother; 2014 May; 69(5):1350-61. PubMed ID: 24474432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Old' antibiotics for emerging multidrug-resistant bacteria.
    Bergen PJ; Landersdorfer CB; Lee HJ; Li J; Nation RL
    Curr Opin Infect Dis; 2012 Dec; 25(6):626-33. PubMed ID: 23041772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.